Business Standard

Granules India divests entire stake in JV Biocause Pharmaceutical

Shares of Granules India Ltd were trading at Rs 146 a piece on BSE

FPI, Foreign portfolio investors, investors, corporate, companies, shareholders, stake, stock
Premium

Illustration by Binay Sinha

Press Trust of India New Delhi
Granules India Ltd on Tuesday said it has divested its entire stake in Granules-Biocause Pharmaceutical Co Limited, a joint venture company located in China.

Last year, Granules India had intimated about the divestment of the entire stake of the JV company for a total consideration of RMB 109 million (around Rs 110.8 crore).

"... the transaction is completed and Granules-Biocause Pharmaceutical Co Limited ceased to be the joint venture company of Granules India Limited," Granules India said in a regulatory filing.

Shares of Granules India Ltd were trading at Rs 146 a piece on BSE, up 0.41 per cent from the previous close.  

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in